CN Stock MarketDetailed Quotes

688046 GemPharmatech

Watchlist
  • 10.91
  • +0.19+1.77%
Market Closed Aug 30 15:00 CST
4.47BMarket Cap28.34P/E (TTM)

GemPharmatech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
15.05%340.38M
11.96%157.09M
20.45%622.19M
17.68%454.56M
18.17%295.86M
20.82%140.3M
31.17%516.55M
38.09%386.28M
40.29%250.37M
51.16%116.12M
Operating revenue
15.05%340.38M
11.96%157.09M
20.45%622.19M
17.68%454.56M
18.17%295.86M
20.82%140.3M
31.17%516.55M
38.09%386.28M
40.29%250.37M
51.16%116.12M
Total operating cost
16.01%267.44M
16.41%127.21M
23.98%486.13M
22.50%349.77M
29.83%230.52M
30.12%109.28M
35.20%392.09M
40.69%285.52M
37.96%177.56M
46.97%83.98M
Operating cost
29.51%120.75M
24.03%53.42M
36.33%201.52M
35.87%140.29M
50.88%93.24M
59.21%43.07M
46.23%147.82M
48.48%103.26M
36.19%61.79M
32.51%27.05M
Operating tax surcharges
61.42%1.29M
-8.88%369.39K
53.47%2.64M
33.17%1.19M
9.39%801.47K
184.10%405.38K
8.21%1.72M
-6.69%892.42K
-0.22%732.67K
45.70%142.69K
Operating expense
16.36%44.91M
23.39%22.3M
7.71%82.22M
-1.74%57.01M
6.11%38.6M
5.35%18.07M
42.77%76.34M
51.75%58.03M
59.41%36.38M
87.71%17.15M
Administration expense
16.58%64.72M
16.17%31.01M
19.27%117.39M
18.30%87.14M
17.56%55.51M
19.80%26.69M
21.59%98.43M
26.64%73.66M
27.50%47.22M
29.94%22.28M
Financial expense
35.36%-5.23M
9.77%-2.88M
5.99%-14.23M
5.70%-11.17M
-12.72%-8.08M
-682.77%-3.2M
-564.02%-15.14M
-476.70%-11.84M
-677.03%-7.17M
17.90%-408.21K
-Interest expense (Financial expense)
101.13%2.16M
149.33%979.08K
457.32%2.76M
752.20%1.82M
202.10%1.07M
44.16%392.69K
-33.47%495.53K
-51.46%213.82K
154.75%355.2K
215.90%272.39K
-Interest Income (Financial expense)
13.57%-7.05M
-0.31%-3.87M
-20.29%-17.13M
-19.99%-12.63M
-19.99%-8.16M
-422.08%-3.85M
-330.03%-14.24M
-303.29%-10.53M
-459.63%-6.8M
-21.11%-738.26K
Research and development
-18.78%40.98M
-5.07%23M
16.48%96.6M
22.38%75.31M
30.68%50.46M
36.45%24.23M
50.23%82.93M
61.51%61.53M
63.17%38.61M
63.85%17.76M
Credit Impairment Loss
-13.23%-8.11M
-4.64%-3.13M
-36.88%-9.39M
-100.71%-9.77M
-35.54%-7.16M
32.20%-2.99M
1.37%-6.86M
28.68%-4.87M
-60.66%-5.28M
-218.27%-4.41M
Asset Impairment Loss
-27.65%-12.78M
-12.20%-6.46M
-42.14%-21.72M
-37.43%-13.86M
-65.82%-10.01M
-120.41%-5.76M
-8.55%-15.28M
13.64%-10.09M
19.52%-6.04M
23.52%-2.61M
Adjustment items of total operating cost
----
----
----
----
-100.00%-0.02
----
----
----
---0.01
---0.01
Other net revenue
Fair value change income
50.51%2.37M
-47.87%1.22M
6,058.80%2.73M
-87.28%1.11M
-44.51%1.58M
1,379.13%2.34M
-114.30%-45.74K
469.71%8.72M
37.61%2.84M
36.90%158.23K
Invest income
9.35%6.72M
517.78%4.16M
21.40%11.52M
105.50%9.68M
80.09%6.15M
-57.35%673.48K
-14.64%9.49M
-26.24%4.71M
1.96%3.41M
-25.27%1.58M
-Including: Investment income associates
-121.18%-106.45K
-78.47%63.78K
142.95%662.13K
258.84%459.6K
367.32%502.61K
266.64%296.18K
-2,099.40%-1.54M
-9,540.05%-289.35K
---188.02K
--80.78K
Asset deal income
----
----
82.96%-17.19K
82.96%-17.19K
82.07%-17.19K
----
---100.89K
---100.89K
---95.91K
---26.18K
Other revenue
-37.00%16.26M
-64.73%2.55M
-28.53%44.53M
-30.79%32.14M
0.48%25.81M
-11.42%7.22M
26.89%62.3M
45.30%46.44M
220.95%25.68M
94.17%8.15M
Adjusted Items effecting operating profit
200.00%0.01
---0.01
----
----
---0.01
----
--0.01
----
----
---0.01
Operating profit
-5.22%77.42M
-13.23%28.21M
-5.90%163.69M
-14.77%124.07M
-12.47%81.69M
-7.05%32.51M
21.42%173.95M
48.29%145.57M
78.13%93.33M
64.17%34.98M
Add:Non operating Income
-39.59%1.48
----
264,432.87%7.57K
4,975,445.61%85.08K
920.83%2.45
684.62%1.02
-99.99%2.86
-99.94%1.71
-99.99%0.24
-100.00%0.13
Less:Non operating expense
-25.09%7.53K
--6.3K
785.75%2.41M
-58.06%114K
-51.63%10.06K
----
411,133.10%271.83K
411,133.10%271.83K
--20.79K
--792.07
Add:Adjusted items effecting total profit
----
----
----
--0.01
----
----
----
----
----
----
Total profit
-5.22%77.41M
-13.25%28.2M
-7.14%161.29M
-14.63%124.04M
-12.47%81.68M
-7.05%32.51M
21.19%173.68M
48.01%145.3M
78.08%93.31M
64.14%34.98M
Less:Income tax cost
-73.88%1.07M
-187.20%-1.27M
-73.67%2.37M
-63.17%6.33M
-64.81%4.11M
-68.59%1.46M
-50.97%9.02M
34.68%17.17M
92.81%11.67M
47.90%4.65M
Add:Adjusted items effecting net profit
---0.01
----
----
----
----
----
----
----
----
----
Net profit
-1.59%76.34M
-5.06%29.48M
-3.49%158.91M
-8.13%117.71M
-4.98%77.57M
2.39%31.05M
31.81%164.67M
50.00%128.13M
76.16%81.64M
66.95%30.32M
Net profit from continuing operation
-1.59%76.34M
-5.06%29.48M
-3.49%158.91M
-8.13%117.71M
-4.98%77.57M
2.39%31.05M
31.81%164.67M
50.00%128.13M
76.16%81.64M
66.95%30.32M
Net profit of parent company owners
-1.59%76.34M
-5.06%29.48M
-3.49%158.91M
-8.13%117.71M
-4.98%77.57M
2.39%31.05M
31.81%164.67M
50.00%128.13M
76.16%81.64M
66.95%30.32M
Earning per share
Basic earning per share
0.00%0.19
-12.50%0.07
-7.14%0.39
-12.12%0.29
-13.64%0.19
0.00%0.08
20.00%0.42
37.50%0.33
69.23%0.22
60.00%0.08
Diluted earning per share
0.00%0.19
-12.50%0.07
-7.14%0.39
-12.12%0.29
-13.64%0.19
0.00%0.08
20.00%0.42
37.50%0.33
69.23%0.22
60.00%0.08
Other composite income
-71.64%138.21K
142.05%74.05K
-72.44%176.65K
-42.23%398.82K
306.74%487.28K
-343.89%-176.07K
65.21%641.06K
29.59%690.4K
-77.10%119.8K
-119.83%-39.67K
Other composite income of parent company owners
-71.64%138.21K
142.05%74.05K
-72.44%176.65K
-42.23%398.82K
306.74%487.28K
-343.89%-176.07K
65.21%641.06K
29.59%690.4K
-77.10%119.8K
-119.83%-39.67K
Total composite income
-2.02%76.48M
-4.28%29.55M
-3.76%159.09M
-8.31%118.11M
-4.52%78.06M
1.95%30.87M
31.91%165.31M
49.88%128.82M
74.45%81.75M
64.92%30.28M
Total composite income of parent company owners
-2.02%76.48M
-4.28%29.55M
-3.76%159.09M
-8.31%118.11M
-4.52%78.06M
1.95%30.87M
31.91%165.31M
49.88%128.82M
74.45%81.75M
64.92%30.28M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 15.05%340.38M11.96%157.09M20.45%622.19M17.68%454.56M18.17%295.86M20.82%140.3M31.17%516.55M38.09%386.28M40.29%250.37M51.16%116.12M
Operating revenue 15.05%340.38M11.96%157.09M20.45%622.19M17.68%454.56M18.17%295.86M20.82%140.3M31.17%516.55M38.09%386.28M40.29%250.37M51.16%116.12M
Total operating cost 16.01%267.44M16.41%127.21M23.98%486.13M22.50%349.77M29.83%230.52M30.12%109.28M35.20%392.09M40.69%285.52M37.96%177.56M46.97%83.98M
Operating cost 29.51%120.75M24.03%53.42M36.33%201.52M35.87%140.29M50.88%93.24M59.21%43.07M46.23%147.82M48.48%103.26M36.19%61.79M32.51%27.05M
Operating tax surcharges 61.42%1.29M-8.88%369.39K53.47%2.64M33.17%1.19M9.39%801.47K184.10%405.38K8.21%1.72M-6.69%892.42K-0.22%732.67K45.70%142.69K
Operating expense 16.36%44.91M23.39%22.3M7.71%82.22M-1.74%57.01M6.11%38.6M5.35%18.07M42.77%76.34M51.75%58.03M59.41%36.38M87.71%17.15M
Administration expense 16.58%64.72M16.17%31.01M19.27%117.39M18.30%87.14M17.56%55.51M19.80%26.69M21.59%98.43M26.64%73.66M27.50%47.22M29.94%22.28M
Financial expense 35.36%-5.23M9.77%-2.88M5.99%-14.23M5.70%-11.17M-12.72%-8.08M-682.77%-3.2M-564.02%-15.14M-476.70%-11.84M-677.03%-7.17M17.90%-408.21K
-Interest expense (Financial expense) 101.13%2.16M149.33%979.08K457.32%2.76M752.20%1.82M202.10%1.07M44.16%392.69K-33.47%495.53K-51.46%213.82K154.75%355.2K215.90%272.39K
-Interest Income (Financial expense) 13.57%-7.05M-0.31%-3.87M-20.29%-17.13M-19.99%-12.63M-19.99%-8.16M-422.08%-3.85M-330.03%-14.24M-303.29%-10.53M-459.63%-6.8M-21.11%-738.26K
Research and development -18.78%40.98M-5.07%23M16.48%96.6M22.38%75.31M30.68%50.46M36.45%24.23M50.23%82.93M61.51%61.53M63.17%38.61M63.85%17.76M
Credit Impairment Loss -13.23%-8.11M-4.64%-3.13M-36.88%-9.39M-100.71%-9.77M-35.54%-7.16M32.20%-2.99M1.37%-6.86M28.68%-4.87M-60.66%-5.28M-218.27%-4.41M
Asset Impairment Loss -27.65%-12.78M-12.20%-6.46M-42.14%-21.72M-37.43%-13.86M-65.82%-10.01M-120.41%-5.76M-8.55%-15.28M13.64%-10.09M19.52%-6.04M23.52%-2.61M
Adjustment items of total operating cost -----------------100.00%-0.02---------------0.01---0.01
Other net revenue
Fair value change income 50.51%2.37M-47.87%1.22M6,058.80%2.73M-87.28%1.11M-44.51%1.58M1,379.13%2.34M-114.30%-45.74K469.71%8.72M37.61%2.84M36.90%158.23K
Invest income 9.35%6.72M517.78%4.16M21.40%11.52M105.50%9.68M80.09%6.15M-57.35%673.48K-14.64%9.49M-26.24%4.71M1.96%3.41M-25.27%1.58M
-Including: Investment income associates -121.18%-106.45K-78.47%63.78K142.95%662.13K258.84%459.6K367.32%502.61K266.64%296.18K-2,099.40%-1.54M-9,540.05%-289.35K---188.02K--80.78K
Asset deal income --------82.96%-17.19K82.96%-17.19K82.07%-17.19K-------100.89K---100.89K---95.91K---26.18K
Other revenue -37.00%16.26M-64.73%2.55M-28.53%44.53M-30.79%32.14M0.48%25.81M-11.42%7.22M26.89%62.3M45.30%46.44M220.95%25.68M94.17%8.15M
Adjusted Items effecting operating profit 200.00%0.01---0.01-----------0.01------0.01-----------0.01
Operating profit -5.22%77.42M-13.23%28.21M-5.90%163.69M-14.77%124.07M-12.47%81.69M-7.05%32.51M21.42%173.95M48.29%145.57M78.13%93.33M64.17%34.98M
Add:Non operating Income -39.59%1.48----264,432.87%7.57K4,975,445.61%85.08K920.83%2.45684.62%1.02-99.99%2.86-99.94%1.71-99.99%0.24-100.00%0.13
Less:Non operating expense -25.09%7.53K--6.3K785.75%2.41M-58.06%114K-51.63%10.06K----411,133.10%271.83K411,133.10%271.83K--20.79K--792.07
Add:Adjusted items effecting total profit --------------0.01------------------------
Total profit -5.22%77.41M-13.25%28.2M-7.14%161.29M-14.63%124.04M-12.47%81.68M-7.05%32.51M21.19%173.68M48.01%145.3M78.08%93.31M64.14%34.98M
Less:Income tax cost -73.88%1.07M-187.20%-1.27M-73.67%2.37M-63.17%6.33M-64.81%4.11M-68.59%1.46M-50.97%9.02M34.68%17.17M92.81%11.67M47.90%4.65M
Add:Adjusted items effecting net profit ---0.01------------------------------------
Net profit -1.59%76.34M-5.06%29.48M-3.49%158.91M-8.13%117.71M-4.98%77.57M2.39%31.05M31.81%164.67M50.00%128.13M76.16%81.64M66.95%30.32M
Net profit from continuing operation -1.59%76.34M-5.06%29.48M-3.49%158.91M-8.13%117.71M-4.98%77.57M2.39%31.05M31.81%164.67M50.00%128.13M76.16%81.64M66.95%30.32M
Net profit of parent company owners -1.59%76.34M-5.06%29.48M-3.49%158.91M-8.13%117.71M-4.98%77.57M2.39%31.05M31.81%164.67M50.00%128.13M76.16%81.64M66.95%30.32M
Earning per share
Basic earning per share 0.00%0.19-12.50%0.07-7.14%0.39-12.12%0.29-13.64%0.190.00%0.0820.00%0.4237.50%0.3369.23%0.2260.00%0.08
Diluted earning per share 0.00%0.19-12.50%0.07-7.14%0.39-12.12%0.29-13.64%0.190.00%0.0820.00%0.4237.50%0.3369.23%0.2260.00%0.08
Other composite income -71.64%138.21K142.05%74.05K-72.44%176.65K-42.23%398.82K306.74%487.28K-343.89%-176.07K65.21%641.06K29.59%690.4K-77.10%119.8K-119.83%-39.67K
Other composite income of parent company owners -71.64%138.21K142.05%74.05K-72.44%176.65K-42.23%398.82K306.74%487.28K-343.89%-176.07K65.21%641.06K29.59%690.4K-77.10%119.8K-119.83%-39.67K
Total composite income -2.02%76.48M-4.28%29.55M-3.76%159.09M-8.31%118.11M-4.52%78.06M1.95%30.87M31.91%165.31M49.88%128.82M74.45%81.75M64.92%30.28M
Total composite income of parent company owners -2.02%76.48M-4.28%29.55M-3.76%159.09M-8.31%118.11M-4.52%78.06M1.95%30.87M31.91%165.31M49.88%128.82M74.45%81.75M64.92%30.28M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg